TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Control Bionics Ltd. ( (AU:CBL) ) is now available.
Control Bionics Ltd. has addressed inquiries from the Australian Securities Exchange regarding its recent financial disclosures. The company reported a consolidated revenue of $6,144,907 and a loss of $6,108,667 for the fiscal year ending June 30, 2025. Despite the financial loss, Control Bionics maintains compliance with relevant listing rules and regulations, ensuring transparency and accountability to its stakeholders.
More about Control Bionics Ltd.
Control Bionics Ltd. operates in the assistive technology industry, focusing on developing and providing communication devices for individuals with disabilities. The company is known for its innovative solutions that enable users to communicate and interact with technology using neural signals.
Average Trading Volume: 152,917
Technical Sentiment Signal: Sell
Current Market Cap: A$12.37M
For an in-depth examination of CBL stock, go to TipRanks’ Overview page.